Evaluation of cerebral vasospasm with transcranial magnetic stimulation: An experimental study

Clinical and Experimental Medicine

Volumn 1, Issue 1, 2001, Pages 43-49

  Goksel H M ^a   Akgun M ^b   Topalkara, K ^b   Solak, O ^b   Topaktas S ^b  

^a C U Hastanesi Beyin Sinir Cerrahi B1 ^*  (Turkey)

^b CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cerebral ischemia transient; Deferoxamine; Evoked response

Indexed keywords

DEFEROXAMINE; DEFEROXAMINE MESYLATE;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN VASOSPASM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EVALUATION; EVOKED MUSCLE RESPONSE; FEMALE; FOLLOW UP; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBARACHNOID HEMORRHAGE; TRANSCRANIAL MAGNETIC STIMULATION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0034788754     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-001-8009-0     Document Type: Article

References (27)

1. Cortical silent period evoked by transcranial magnetic stimulation in ischemic stroke
2. The effect of deferoxamine on brain lipid peroxide levels and Na-K ATPase activity, following experimental subarachnoid hemorrhage
3. The prevention of oxyhemoglobin-induced endothelial and smooth muscle cytoskeletal injury by deferoxamine
4. Protective effects of combined superoxide dismutase and deferoxamine on recovery of cerebral blood flow and function after cardiac arrest in dogs
5. Brain stimulation revisited
6. Subarachnoid hemorrhage in the rat: Angiography and fluorescence microscopy of the major cerebral arteries
7. Transcranial magnetic motor evoked potentials for functional monitoring of motor pathways during scoliosis surgery
8. Experimental model of symptomatic vasospasm in rabbits
9. Prognostic value of motor evoked potential obtained by transcranial magnetic brain stimulation in motor function recovery in patients with acute ischemic stroke
10. Motor evoked potentials recorded from normal and spinal cord injured rats
11. Failure of deferoxamine, an iron chelator, to improve neurologic outcome following complete cerebral ischemia in dogs
12. Optimal stimulus duration for extracranial cortical stimulation
13. Anesthesia and analgesia
14. Inhibition of delayed arterial narrowing by the iron-chelating agent deferoxamine
15. Dependence of cerebral energy phosphate and evoked potential recovery on end-ischemic pH
16. Origins and conducting pathways of motor evoked potentials elicited by transcranial magnetic stimulation in cats
17. Effects of high-dose methyl-prednisolone on Na-K ATPase and lipid peroxidation after experimental SAH
18. Effect of the 21-aminosteroid trilazad on cerebral pH and somatosensory evoked potential after incomplete ischemia
19. Motor evoked potentials in unilateral lingual paralysis after monohemispheric ischemia
20. Postischemic recovery rate of cerebral ATP, phosphocreatine, pH and evoked potentials
21. Cerebral vasospasm
22. Can motor recovery in stroke patients be predicted by early transcranial magnetic stimulation?
23. Mechanisms of nervous propagation along central motor pathways: Noninvasive evaluation in healthy subjects and in patients with neurological disease
24. Correlation between functional and electrophysiological recovery in acute ischemic stroke
25. A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage
26. Cerebral vasospasm
27. Magnetic motor evoked potentials during methohexital anesthesia in the dog